FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100335439> ?p ?o ?g. }

• W3100335439 endingPage "696" @default.
• W3100335439 startingPage "684" @default.
• W3100335439 abstract "Abstract Aims To investigate the effects of spironolactone on fibrosis and cardiac function in people at increased risk of developing heart failure. Methods and results Randomized, open-label, blinded-endpoint trial comparing spironolactone (50 mg/day) or control for up to 9 months in people with, or at high risk of, coronary disease and raised plasma B-type natriuretic peptides. The primary endpoint was the interaction between baseline serum galectin-3 and changes in serum procollagen type-III N-terminal pro-peptide (PIIINP) in participants assigned to spironolactone or control. Procollagen type-I C-terminal pro-peptide (PICP) and collagen type-1 C-terminal telopeptide (CITP), reflecting synthesis and degradation of type-I collagen, were also measured. In 527 participants (median age 73 years, 26% women), changes in PIIINP were similar for spironolactone and control [mean difference (mdiff): −0.15; 95% confidence interval (CI) −0.44 to 0.15 μg/L; P = 0.32] but those receiving spironolactone had greater reductions in PICP (mdiff: −8.1; 95% CI −11.9 to −4.3 μg/L; P &lt; 0.0001) and PICP/CITP ratio (mdiff: −2.9; 95% CI −4.3 to −1.5; &lt;0.0001). No interactions with serum galectin were observed. Systolic blood pressure (mdiff: −10; 95% CI −13 to −7 mmHg; P &lt; 0.0001), left atrial volume (mdiff: −1; 95% CI −2 to 0 mL/m2; P = 0.010), and NT-proBNP (mdiff: −57; 95% CI −81 to −33 ng/L; P &lt; 0.0001) were reduced in those assigned spironolactone. Conclusions Galectin-3 did not identify greater reductions in serum concentrations of collagen biomarkers in response to spironolactone. However, spironolactone may influence type-I collagen metabolism. Whether spironolactone can delay or prevent progression to symptomatic heart failure should be investigated." @default.
• W3100335439 created "2020-11-23" @default.
• W3100335439 creator A5000033905 @default.
• W3100335439 creator A5001704230 @default.
• W3100335439 creator A5001853031 @default.
• W3100335439 creator A5003344321 @default.
• W3100335439 creator A5005230910 @default.
• W3100335439 creator A5006510755 @default.
• W3100335439 creator A5008530481 @default.
• W3100335439 creator A5008989410 @default.
• W3100335439 creator A5009905903 @default.
• W3100335439 creator A5017160240 @default.
• W3100335439 creator A5021920910 @default.
• W3100335439 creator A5022315247 @default.
• W3100335439 creator A5027518592 @default.
• W3100335439 creator A5033703477 @default.
• W3100335439 creator A5036821495 @default.
• W3100335439 creator A5037255844 @default.
• W3100335439 creator A5042761326 @default.
• W3100335439 creator A5043512811 @default.
• W3100335439 creator A5049803947 @default.
• W3100335439 creator A5052219767 @default.
• W3100335439 creator A5057514332 @default.
• W3100335439 creator A5057864298 @default.
• W3100335439 creator A5061900184 @default.
• W3100335439 creator A5063949568 @default.
• W3100335439 creator A5065724319 @default.
• W3100335439 creator A5066609762 @default.
• W3100335439 creator A5070569716 @default.
• W3100335439 creator A5073781406 @default.
• W3100335439 creator A5075620293 @default.
• W3100335439 creator A5088543148 @default.
• W3100335439 date "2020-11-20" @default.
• W3100335439 modified "2023-10-15" @default.
• W3100335439 title "The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial" @default.
• W3100335439 cites W1676600749 @default.
• W3100335439 cites W1797367453 @default.
• W3100335439 cites W1893887535 @default.
• W3100335439 cites W1957009538 @default.
• W3100335439 cites W1977437151 @default.
• W3100335439 cites W1980698063 @default.
• W3100335439 cites W1981384991 @default.
• W3100335439 cites W1986918198 @default.
• W3100335439 cites W1992700728 @default.
• W3100335439 cites W1999321766 @default.
• W3100335439 cites W2001513063 @default.
• W3100335439 cites W2005025387 @default.
• W3100335439 cites W2060018075 @default.
• W3100335439 cites W2064854697 @default.
• W3100335439 cites W2073742622 @default.
• W3100335439 cites W2106493153 @default.
• W3100335439 cites W2113829060 @default.
• W3100335439 cites W2143795945 @default.
• W3100335439 cites W2160070302 @default.
• W3100335439 cites W2171981556 @default.
• W3100335439 cites W2256402734 @default.
• W3100335439 cites W2342308986 @default.
• W3100335439 cites W2394582615 @default.
• W3100335439 cites W2526914029 @default.
• W3100335439 cites W2565882387 @default.
• W3100335439 cites W2583626617 @default.
• W3100335439 cites W2598019630 @default.
• W3100335439 cites W2611251542 @default.
• W3100335439 cites W2770196824 @default.
• W3100335439 cites W2770756683 @default.
• W3100335439 cites W2885798290 @default.
• W3100335439 cites W2889352094 @default.
• W3100335439 cites W2915837534 @default.
• W3100335439 cites W2946048817 @default.
• W3100335439 cites W2946963067 @default.
• W3100335439 cites W2990806422 @default.
• W3100335439 cites W2999232240 @default.
• W3100335439 cites W3014993169 @default.
• W3100335439 cites W604783079 @default.
• W3100335439 doi "https://doi.org/10.1093/eurheartj/ehaa758" @default.
• W3100335439 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7878013" @default.
• W3100335439 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33215209" @default.
• W3100335439 hasPublicationYear "2020" @default.
• W3100335439 type Work @default.
• W3100335439 sameAs 3100335439 @default.
• W3100335439 citedByCount "63" @default.
• W3100335439 countsByYear W31003354392020 @default.
• W3100335439 countsByYear W31003354392021 @default.
• W3100335439 countsByYear W31003354392022 @default.
• W3100335439 countsByYear W31003354392023 @default.
• W3100335439 crossrefType "journal-article" @default.
• W3100335439 hasAuthorship W3100335439A5000033905 @default.
• W3100335439 hasAuthorship W3100335439A5001704230 @default.
• W3100335439 hasAuthorship W3100335439A5001853031 @default.
• W3100335439 hasAuthorship W3100335439A5003344321 @default.
• W3100335439 hasAuthorship W3100335439A5005230910 @default.
• W3100335439 hasAuthorship W3100335439A5006510755 @default.
• W3100335439 hasAuthorship W3100335439A5008530481 @default.
• W3100335439 hasAuthorship W3100335439A5008989410 @default.
• W3100335439 hasAuthorship W3100335439A5009905903 @default.
• W3100335439 hasAuthorship W3100335439A5017160240 @default.
• W3100335439 hasAuthorship W3100335439A5021920910 @default.
• W3100335439 hasAuthorship W3100335439A5022315247 @default.

• next